Economic impact of visual impairment and blindness in the United States

Archives of Ophthalmology

Volumn 125, Issue 4, 2007, Pages 544-550

  Frick, Kevin D ^a   Gower, Emily W ^b   Kempen, John H ^c   Wolff, Jennifer L ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLINDNESS; CONTROLLED STUDY; DISEASE ASSOCIATION; ECONOMIC ASPECT; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL INFORMATION; PRIORITY JOURNAL; QUALITY OF LIFE; SELF REPORT; UNITED STATES; VISUAL IMPAIRMENT;

ADULT; BLINDNESS; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; UNITED STATES; VISION, LOW; VISUALLY IMPAIRED PERSONS;

EID: 34247098266     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.4.544     Document Type: Article

References (24)

1. Frick KD, Kymes SM. The calculation and use of economic burden data. Br J Ophthalmol. 2006;90:255-257.
2. Chiang YP, Bassi LJ, Javitt JC. Federal budgetary costs of blindness. Milbank Q. 1992;70:319-340.
3. Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br J Ophthalmol. 2006;90:272-275.
4. Frick KD, Foster A. The magnitude and cost of global blindness: an increasing problem that can be alleviated. Am J Ophthalmol. 2003;135:471-476.
5. Smith AF, Smith JG. The economic burden of global blindness: a price too high! Br J Ophthalmol. 1996;80:276-277.
6. Cohen SB. Design strategies and innovations in the medical expenditure panel survey. Med Care. 2003;41(7 suppl):III5-III12.
7. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood). 2003;Suppl Web Exclusives:W3-219-W3-226. doi:10.1377/hlthaff.w3.219.
8. Yelin E, Herrndorf A, Trupin L, Sonneborn D. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care. Arthritis Rheum. 2001;44:1160-1169.
9. Guevara JP, Mandell DS, Rostain AL, Zhao H, Hadley TR. National estimates of health services expenditures for children with behavioral disorders: an analysis of the medical expenditure panel survey. Pediatrics. 2003;112:e440.
10. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
11. Center for Financing, Access, and Cost Trends. MEPS HC-036: 1996-2003 Pooled Estimation File. Rockville, Md: Agency for Healthcare Research and Quality; 2005.
12. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
13. US Department of Labor, Bureau of Labor Statistics. Consumer price indexes. http://www.bls.gov/cpi/home.htm#data. Accessed June 30, 2006.
14. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-1108.
15. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203-220.
16. Brown MM, Brown GC, Sharma S, Kistler J, Brown H. Utility values associated with blindness in an adult population. Br J Ophthalmol. 2001;85:327-331.
17. Mullahy J. Much ado about two: reconsidering retransformation and the two-part model in health econometrics. J Health Econ. 1998;17:247-281.
18. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461-494.
19. Prevent Blindness America; National Eye Institute. Vision Problems in the US: Prevalence of Adult Vision Impairment and Age-Related Eye Disease in America. Schaumburg, Ill: Prevent Blindness America; 2002.
20. US Census Bureau. State interim population projections by age and sex: 2004-2030. http://www.census.gov/population/www/projections/projectionsagesex. html. Accessed June 21, 2006.
21. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
22. Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making. 1998;18(2 suppl): S68-S80.
23. Hirth RA, Chernew ME, Miller E, Fendrick AM, Weissert WG. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making. 2000;20:332-342.
24. Furlong W, Feeny D, Torrance GW, et al. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report. Hamilton, Ontario: McMaster University Centre for Health Economics and Policy Analysis; 1998. Working Paper 98-11.